| Year |
Citation |
Score |
| 2020 |
Sofian ZM, Benaouda F, Wang JT, Lu Y, Barlow DJ, Royall PG, Farag DB, Rahman KM, Al-Jamal KT, Forbes B, Jones SA. A Cyclodextrin-Stabilized Spermine-Tagged Drug Triplex that Targets Theophylline to the Lungs Selectively in Respiratory Emergency. Advanced Therapeutics. 2000153. PMID 33043128 DOI: 10.1002/adtp.202000153 |
0.551 |
|
| 2020 |
Lee DDH, Cardinale D, Terakosolphan W, Sornsute A, Radhakrishnan P, Coppel J, Smith CM, Satyanarayana S, Forbes B, O'Callaghan C. Fluticasone Particles Bind to Motile Respiratory Cilia: A Mechanism for Enhanced Lung and Systemic Exposure? Journal of Aerosol Medicine and Pulmonary Drug Delivery. PMID 32960118 DOI: 10.1089/Jamp.2020.1598 |
0.317 |
|
| 2020 |
Muddle J, Kanabar V, Brown M, Page C, Forbes B. An in vitro bioassay for evaluating the effect of inhaled bronchodilators on airway smooth muscle. Pulmonary Pharmacology & Therapeutics. 101943. PMID 32889156 DOI: 10.1016/J.Pupt.2020.101943 |
0.353 |
|
| 2020 |
Patel A, Redinger N, Richter A, Woods A, Neumann PR, Keegan G, Childerhouse N, Imming P, Schaible UE, Forbes B, Dailey LA. In vitro and in vivo antitubercular activity of benzothiazinone-loaded human serum albumin nanocarriers designed for inhalation. Journal of Controlled Release : Official Journal of the Controlled Release Society. 328: 339-349. PMID 32827612 DOI: 10.1016/J.Jconrel.2020.08.022 |
0.37 |
|
| 2020 |
Cunha S, Costa CP, Loureiro JA, Alves J, Peixoto AF, Forbes B, Sousa Lobo JM, Silva AC. Double Optimization of Rivastigmine-Loaded Nanostructured Lipid Carriers (NLC) for Nose-to-Brain Delivery Using the Quality by Design (QbD) Approach: Formulation Variables and Instrumental Parameters. Pharmaceutics. 12. PMID 32605177 DOI: 10.3390/Pharmaceutics12070599 |
0.324 |
|
| 2020 |
Videira MA, Llop J, Sousa C, Kreutzer B, Cossío U, Forbes B, Vieira I, Gil N, Silva-Lima B. Pulmonary Administration: Strengthening the Value of Therapeutic Proximity. Frontiers in Medicine. 7: 50. PMID 32181253 DOI: 10.3389/Fmed.2020.00050 |
0.311 |
|
| 2020 |
Dutton B, Woods A, Sadler R, Prime D, Barlow DJ, Forbes B, Jones SA. Using polar ion-pairs to control drug delivery to the airways of the lungs. Molecular Pharmaceutics. PMID 32101010 DOI: 10.1021/Acs.Molpharmaceut.9B01166 |
0.368 |
|
| 2020 |
Forbes B, Bommer R, Goole J, Hellfritzsch M, de Kruijf W, Lambert P, Caivano G, Regard A, Schiaretti F, Trenkel M, Vecellio L, Williams G, Sonvico F, Scherließ R. A consensus research agenda for optimising nasal drug delivery. Expert Opinion On Drug Delivery. PMID 31928241 DOI: 10.1080/17425247.2020.1714589 |
0.361 |
|
| 2019 |
Dexter A, Steven RT, Patel A, Dailey LA, Taylor AJ, Ball D, Klapwijk J, Forbes B, Page CP, Bunch J. Imaging drugs, metabolites and biomarkers in rodent lung: a DESI MS strategy for the evaluation of drug-induced lipidosis. Analytical and Bioanalytical Chemistry. PMID 31776643 DOI: 10.1007/S00216-019-02151-Z |
0.315 |
|
| 2019 |
Woods A, Andrian T, Sharp G, Melis Bicer E, Vandera KA, Patel A, Mudway I, Ann Dailey L, Forbes B. Development of new in vitro models of lung protease activity for investigating stability of inhaled biological therapies and drug delivery systems. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 31756380 DOI: 10.1016/J.Ejpb.2019.11.005 |
0.395 |
|
| 2019 |
Patel A, Hoffman E, Ball D, Klapwijk J, Steven RT, Dexter A, Bunch J, Baker D, Murnane D, Hutter V, Page C, Dailey LA, Forbes B. Comparison of Oral, Intranasal and Aerosol Administration of Amiodarone in Rats as a Model of Pulmonary Phospholipidosis. Pharmaceutics. 11. PMID 31319538 DOI: 10.3390/Pharmaceutics11070345 |
0.349 |
|
| 2019 |
Chen H, Mansfield EDH, Woods A, Khutoryanskiy VV, Forbes B, Jones SA. Mucus penetrating properties of soft, distensible lipid nanocapsules. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 30818012 DOI: 10.1016/J.Ejpb.2019.02.020 |
0.329 |
|
| 2019 |
Hassoun M, Malmlof M, Scheibelhofer O, Kumar A, Bansal S, Selg E, Nowenwik M, Gerde P, Radivojev S, Paudel A, Arora S, Forbes B. Use of PBPK modelling to evaluate the performance of DissolvIt, a biorelevant dissolution assay for orally inhaled drug products. Molecular Pharmaceutics. PMID 30640475 DOI: 10.1021/Acs.Molpharmaceut.8B01200 |
0.409 |
|
| 2019 |
Martinez MN, Bhoopathy S, Carlert S, Cirit M, Fahmy R, Flanagan T, Forbes B, Jamei M, Khan MA, Lukacova V, Mochel JP, Pepin X, Pade D, Reppas C, Sinko PJ, et al. Workshop Report: USP Workshop on Exploring the Science of Drug Absorption Dissolution Technologies. 26: 38-66. DOI: 10.14227/Dt260319P38 |
0.312 |
|
| 2018 |
Hassoun M, Royall PG, Parry M, Harvey RD, Forbes B. Design and development of a biorelevant simulated human lung fluid. Journal of Drug Delivery Science and Technology. 47: 485-491. PMID 30283501 DOI: 10.1016/J.Jddst.2018.08.006 |
0.363 |
|
| 2018 |
Terakosolphan W, Trick JL, Royall PG, Rogers SE, Lamberti O, Lorenz CD, Forbes B, Harvey RD. Glycerol solvates DPPC headgroups and localises in the interfacial regions of model pulmonary interfaces altering bilayer structure. Langmuir : the Acs Journal of Surfaces and Colloids. PMID 29738253 DOI: 10.1021/Acs.Langmuir.8B00866 |
0.346 |
|
| 2018 |
Lexmond AJ, Keir S, Terakosolphan W, Page CP, Forbes B. A novel method for studying airway hyperresponsiveness in allergic guinea pigs in vivo using the PreciseInhale system for delivery of dry powder aerosols. Drug Delivery and Translational Research. 8: 760-769. PMID 29468423 DOI: 10.1007/S13346-018-0490-Z |
0.353 |
|
| 2018 |
Malallah OS, Garcia CMA, Proctor GB, Forbes B, Royall PG. Buccal drug delivery technologies for patient-centred treatment of radiation-induced xerostomia (dry mouth). International Journal of Pharmaceutics. PMID 29425763 DOI: 10.1016/J.Ijpharm.2018.02.004 |
0.337 |
|
| 2018 |
Lexmond AJ, Singh D, Frijlink HW, Clarke GW, Page CP, Forbes B, van den Berge M. Realising the potential of various inhaled airway challenge agents through improved delivery to the lungs. Pulmonary Pharmacology & Therapeutics. PMID 29331645 DOI: 10.1016/J.Pupt.2018.01.004 |
0.329 |
|
| 2018 |
Benaouda F, Jones SA, Chana J, Dal Corno BM, Barlow DJ, Hider RC, Page CP, Forbes B. Ion-pairing with spermine targets theophylline to the lungs via the polyamine transport system. Molecular Pharmaceutics. PMID 29307184 DOI: 10.1021/Acs.Molpharmaceut.7B00715 |
0.341 |
|
| 2017 |
Bäckman P, Arora S, Couet W, Forbes B, de Kruijf W, Paudel A. Advances in experimental and mechanistic computational models to understand pulmonary exposure to inhaled drugs. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. PMID 29079338 DOI: 10.1016/J.Ejps.2017.10.030 |
0.362 |
|
| 2017 |
Bosquillon C, Madlova M, Patel N, Clear N, Forbes B. A Comparison of Drug Transport in Pulmonary Absorption Models: Isolated Perfused rat Lungs, Respiratory Epithelial Cell Lines and Primary Cell Culture. Pharmaceutical Research. PMID 28924829 DOI: 10.1007/S11095-017-2251-Y |
0.376 |
|
| 2017 |
Swedrowska M, Jamshidi S, Kumar A, Kelly C, Rahman KM, Forbes B. In-silico and in-vitro screening for P-glycoprotein interaction with tenofovir, darunavir and dapivirine: an anti-retroviral drug combination for topical prevention of colorectal HIV transmission. Molecular Pharmaceutics. PMID 28648081 DOI: 10.1021/Acs.Molpharmaceut.7B00133 |
0.348 |
|
| 2017 |
Kumar A, Bicer EM, Pfeffer P, Monopoli MP, Dawson KA, Eriksson J, Edwards K, Lynham S, Arno M, Behndig AF, Blomberg A, Somers G, Hassall D, Dailey LA, Forbes B, et al. Differences in the coronal proteome acquired by particles depositing in the lungs of asthmatic versus healthy humans. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 28647590 DOI: 10.1016/J.Nano.2017.06.008 |
0.353 |
|
| 2017 |
Ehrhardt C, Bäckman P, Couet W, Edwards C, Forbes B, Fridén M, Gumbleton M, Hosoya KI, Kato Y, Nakanishi T, Takano M, Terasaki T, Yumoto R. Current progress toward a better understanding of drug disposition within the lungs: summary proceedings of the 1(st) Workshop on Drug Transporters in the Lungs. Journal of Pharmaceutical Sciences. PMID 28416418 DOI: 10.1016/J.Xphs.2017.04.011 |
0.373 |
|
| 2017 |
Elsaid Z, Taylor KM, Puri S, Eberlein CA, Al-Jamal K, Bai J, Klippstein R, Wang JT, Forbes B, Chana J, Somavarapu S. Mixed micelles of lipoic acid-chitosan-poly(ethylene glycol) and distearoylphosphatidylethanolamine-poly(ethylene glycol) for tumor delivery. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. PMID 28163163 DOI: 10.1016/J.Ejps.2017.02.001 |
0.585 |
|
| 2017 |
Lexmond A, Forbes B. Drug Delivery Devices for Inhaled Medicines. Handbook of Experimental Pharmacology. 237: 265-280. PMID 27812896 DOI: 10.1007/164_2016_67 |
0.388 |
|
| 2016 |
Martinelli F, Balducci AG, Kumar A, Sonvico F, Forbes B, Bettini R, Buttini F. Engineered sodium hyaluronate respirable dry powders for pulmonary drug delivery. International Journal of Pharmaceutics. PMID 27923698 DOI: 10.1016/J.Ijpharm.2016.12.002 |
0.352 |
|
| 2016 |
Muddle J, Kirton SB, Parisini I, Muddle A, Murnane D, Ali J, Brown M, Page C, Forbes B. Predicting the Fine Particle Fraction of Dry Powder Inhalers Using Artificial Neural Networks. Journal of Pharmaceutical Sciences. PMID 27837967 DOI: 10.1016/J.Xphs.2016.10.002 |
0.321 |
|
| 2016 |
Patel A, Woods A, Riffo-Vasquez Y, Babin-Morgan A, Jones MC, Jones S, Sunassee K, Clark S, de Rosales RT, Page C, Spina D, Forbes B, Dailey LA. Lung inflammation does not affect the clearance kinetics of lipid nanocapsules following pulmonary administration. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 27180635 DOI: 10.1016/J.Jconrel.2016.05.024 |
0.353 |
|
| 2016 |
Alqurshi A, Kumar Z, Mcdonald R, Strang J, Buanz A, Ahmed S, Allen E, Cameron P, Rickard JA, Sandhu V, Holt C, Stansfield R, Taylor D, Forbes B, Royall PG. Amorphous formulation and in vitro performance testing of instantly disintegrating buccal tablets for the emergency delivery of naloxone. Molecular Pharmaceutics. PMID 26977787 DOI: 10.1021/Acs.Molpharmaceut.6B00096 |
0.335 |
|
| 2016 |
Kumar A, Bicer EM, Morgan AB, Pfeffer PE, Monopoli M, Dawson KA, Eriksson J, Edwards K, Lynham S, Arno M, Behndig AF, Blomberg A, Somers G, Hassall D, Dailey LA, ... Forbes B, et al. Enrichment of immunoregulatory proteins in the biomolecular corona of nanoparticles within human respiratory tract lining fluid. Nanomedicine : Nanotechnology, Biology, and Medicine. 12: 1033-43. PMID 26767511 DOI: 10.1016/J.Nano.2015.12.369 |
0.341 |
|
| 2015 |
Muddle J, Murnane D, Parisini I, Brown M, Page C, Forbes B. Interaction of Formulation and Device Factors Determine the In Vitro Performance of Salbutamol Sulphate Dry Powders for Inhalation. Journal of Pharmaceutical Sciences. 104: 3861-9. PMID 26220184 DOI: 10.1002/Jps.24599 |
0.304 |
|
| 2015 |
Hassoun M, Ho S, Muddle J, Buttini F, Parry M, Hammond M, Forbes B. Formulating powder-device combinations for salmeterol xinafoate dry powder inhalers. International Journal of Pharmaceutics. 490: 360-7. PMID 25987210 DOI: 10.1016/J.Ijpharm.2015.05.028 |
0.335 |
|
| 2015 |
Woods A, Patel A, Spina D, Riffo-Vasquez Y, Babin-Morgan A, de Rosales RT, Sunassee K, Clark S, Collins H, Bruce K, Dailey LA, Forbes B. In vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 210: 1-9. PMID 25980621 DOI: 10.1016/J.Jconrel.2015.05.269 |
0.385 |
|
| 2015 |
Hoffman E, Kumar A, Kanabar V, Arno M, Preux L, Millar V, Page C, Collins H, Mudway I, Dailey LA, Forbes B. In Vitro Multiparameter Assay Development Strategy toward Differentiating Macrophage Responses to Inhaled Medicines. Molecular Pharmaceutics. 12: 2675-87. PMID 25941945 DOI: 10.1021/Acs.Molpharmaceut.5B00048 |
0.33 |
|
| 2015 |
Kumar A, Forbes B, Mudway I, Bicer EM, Dailey LA. What are the biological and therapeutic implications of biomolecule corona formation on the surface of inhaled nanomedicines? Nanomedicine (London, England). 10: 343-5. PMID 25707971 DOI: 10.2217/Nnm.15.2 |
0.335 |
|
| 2015 |
Chana J, Forbes B, Jones SA. Triggered-release nanocapsules for drug delivery to the lungs. Nanomedicine : Nanotechnology, Biology, and Medicine. 11: 89-97. PMID 25101879 DOI: 10.1016/J.Nano.2014.07.012 |
0.386 |
|
| 2015 |
Dailey LA, Hernández-Prieto R, Casas-Ferreira AM, Jones MC, Riffo-Vasquez Y, Rodríguez-Gonzalo E, Spina D, Jones SA, Smith NW, Forbes B, Page C, Legido-Quigley C. Adenosine monophosphate is elevated in the bronchoalveolar lavage fluid of mice with acute respiratory toxicity induced by nanoparticles with high surface hydrophobicity. Nanotoxicology. 9: 106-15. PMID 24621376 DOI: 10.3109/17435390.2014.894150 |
0.335 |
|
| 2014 |
Jones MC, Jones SA, Riffo-Vasquez Y, Spina D, Hoffman E, Morgan A, Patel A, Page C, Forbes B, Dailey LA. Quantitative assessment of nanoparticle surface hydrophobicity and its influence on pulmonary biocompatibility. Journal of Controlled Release : Official Journal of the Controlled Release Society. 183: 94-104. PMID 24657808 DOI: 10.1016/J.Jconrel.2014.03.022 |
0.301 |
|
| 2014 |
Ong HX, Benaouda F, Traini D, Cipolla D, Gonda I, Bebawy M, Forbes B, Young PM. In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 86: 83-9. PMID 23851077 DOI: 10.1016/J.Ejpb.2013.06.024 |
0.403 |
|
| 2012 |
Silva AC, Kumar A, Wild W, Ferreira D, Santos D, Forbes B. Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles. International Journal of Pharmaceutics. 436: 798-805. PMID 22867992 DOI: 10.1016/J.Ijpharm.2012.07.058 |
0.386 |
|
| 2012 |
Grainger CI, Saunders M, Buttini F, Telford R, Merolla LL, Martin GP, Jones SA, Forbes B. Critical characteristics for corticosteroid solution metered dose inhaler bioequivalence. Molecular Pharmaceutics. 9: 563-9. PMID 22229274 DOI: 10.1021/Mp200415G |
0.344 |
|
| 2012 |
Zughaid H, Forbes B, Martin GP, Patel N. Bile salt composition is secondary to bile salt concentration in determining hydrocortisone and progesterone solubility in intestinal mimetic fluids. International Journal of Pharmaceutics. 422: 295-301. PMID 22101287 DOI: 10.1016/J.Ijpharm.2011.11.012 |
0.338 |
|
| 2012 |
Abhinav K, Magda S, Dailey LA, Mudway I, Siow RCM, Mann GE, Forbes B. Effect of altered oxygen tension on Nrf2-linked glutathione levels in lung epithelial cells challenged with nanoparticles Free Radical Biology and Medicine. 53. DOI: 10.1016/J.Freeradbiomed.2012.08.485 |
0.317 |
|
| 2011 |
Forbes B, Asgharian B, Dailey LA, Ferguson D, Gerde P, Gumbleton M, Gustavsson L, Hardy C, Hassall D, Jones R, Lock R, Maas J, McGovern T, Pitcairn GR, Somers G, et al. Challenges in inhaled product development and opportunities for open innovation. Advanced Drug Delivery Reviews. 63: 69-87. PMID 21144875 DOI: 10.1016/J.Addr.2010.11.004 |
0.4 |
|
| 2011 |
Jones M, Kumar A, Spina D, Forbes B, Page C, Dailey L. In vivo safety and particokinetics of inhaled nanomedicines Journal of Drug Delivery Science and Technology. 21: 339-346. DOI: 10.1016/S1773-2247(11)50052-8 |
0.366 |
|
| 2011 |
Sadler R, Burnell P, Martin G, Forbes B. Integrated in vitro experimental modelling of inhaled drug delivery: deposition, dissolution and absorption Journal of Drug Delivery Science and Technology. 21: 331-338. DOI: 10.1016/S1773-2247(11)50051-6 |
0.369 |
|
| 2010 |
Dos Santos MA, Bosquillon C, Russomano T, Sundaresan A, Falcão F, Marriott C, Forbes B. Modelling the effects of microgravity on the permeability of air interface respiratory epithelial cell layers Advances in Space Research. 46: 712-718. DOI: 10.1016/J.Asr.2010.05.002 |
0.322 |
|
| 2009 |
Madlova M, Jones SA, Zwerschke I, Ma Y, Hider RC, Forbes B. Poly(vinyl alcohol) nanoparticle stability in biological media and uptake in respiratory epithelial cell layers in vitro. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 72: 437-43. PMID 19462480 DOI: 10.1016/J.Ejpb.2009.01.009 |
0.326 |
|
| 2009 |
Gul MO, Jones SA, Dailey LA, Nacer H, Ma Y, Sadouki F, Hider R, Araman A, Forbes B. A poly(vinyl alcohol) nanoparticle platform for kinetic studies of inhaled particles. Inhalation Toxicology. 21: 631-40. PMID 19459777 DOI: 10.1080/08958370802353435 |
0.343 |
|
| 2009 |
Salem LB, Bosquillon C, Dailey LA, Delattre L, Martin GP, Evrard B, Forbes B. Sparing methylation of beta-cyclodextrin mitigates cytotoxicity and permeability induction in respiratory epithelial cell layers in vitro. Journal of Controlled Release : Official Journal of the Controlled Release Society. 136: 110-6. PMID 19331849 DOI: 10.1016/J.Jconrel.2009.01.019 |
0.316 |
|
| 2009 |
van den Bogaard EH, Dailey LA, Thorley AJ, Tetley TD, Forbes B. Inflammatory response and barrier properties of a new alveolar type 1-like cell line (TT1). Pharmaceutical Research. 26: 1172-80. PMID 19199008 DOI: 10.1007/S11095-009-9838-X |
0.302 |
|
| 2009 |
Grainger CI, Greenwell LL, Martin GP, Forbes B. The permeability of large molecular weight solutes following particle delivery to air-interfaced cells that model the respiratory mucosa. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 71: 318-24. PMID 18845252 DOI: 10.1016/J.Ejpb.2008.09.006 |
0.312 |
|
| 2008 |
Manford F, Riffo-Vasquez Y, Spina D, Page CP, Hutt AJ, Moore V, Johansson F, Forbes B. Lack of difference in pulmonary absorption of digoxin, a P-glycoprotein substrate, in mdr1a-deficient and mdr1a-competent mice. The Journal of Pharmacy and Pharmacology. 60: 1305-10. PMID 18812023 DOI: 10.1211/Jpp/60.10.0006 |
0.346 |
|
| 2007 |
Khengar RH, Jones SA, Turner RB, Forbes B, Brown MB. Nail swelling as a pre-formulation screen for the selection and optimisation of ungual penetration enhancers. Pharmaceutical Research. 24: 2207-12. PMID 17665289 DOI: 10.1007/S11095-007-9368-3 |
0.335 |
|
| 2007 |
Grenha A, Grainger CI, Dailey LA, Seijo B, Martin GP, Remuñán-López C, Forbes B. Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 31: 73-84. PMID 17408932 DOI: 10.1016/J.Ejps.2007.02.008 |
0.312 |
|
| 2006 |
Patel N, Forbes B, Eskola S, Murray J. Use of simulated intestinal fluids with Caco-2 cells and rat ileum. Drug Development and Industrial Pharmacy. 32: 151-161. PMID 16537196 DOI: 10.1080/03639040500465991 |
0.304 |
|
| 2005 |
Liao YH, Jones SA, Forbes B, Martin GP, Brown MB. Hyaluronan: pharmaceutical characterization and drug delivery. Drug Delivery. 12: 327-42. PMID 16253949 DOI: 10.1080/10717540590952555 |
0.323 |
|
| 2005 |
Manford F, Tronde A, Jeppsson AB, Patel N, Johansson F, Forbes B. Drug permeability in 16HBE14o- airway cell layers correlates with absorption from the isolated perfused rat lung. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 26: 414-20. PMID 16153810 DOI: 10.1016/J.Ejps.2005.07.010 |
0.37 |
|
| 2005 |
Forbes B, Ehrhardt C. Human respiratory epithelial cell culture for drug delivery applications. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. 60: 193-205. PMID 15939233 DOI: 10.1016/J.Ejpb.2005.02.010 |
0.402 |
|
| 2003 |
Forbes B, Shah A, Martin GP, Lansley AB. The human bronchial epithelial cell line 16HBE14o- as a model system of the airways for studying drug transport. International Journal of Pharmaceutics. 257: 161-7. PMID 12711171 DOI: 10.1016/S0378-5173(03)00129-7 |
0.338 |
|
| 2002 |
Lim ST, Forbes B, Berry DJ, Martin GP, Brown M. In vivo evaluation of novel hyaluronan/chitosan microparticulate delivery systems for the nasal delivery of gentamicin in rabbits. International Journal of Pharmaceutics. 231: 73-82. PMID 11719016 DOI: 10.1016/S0378-5173(01)00873-0 |
0.306 |
|
| 2000 |
Forbes B. Human airway epithelial cell lines for in vitro drug transport and metabolism studies. Pharmaceutical Science & Technology Today. 3: 18-27. PMID 10637597 DOI: 10.1016/S1461-5347(99)00231-X |
0.389 |
|
| 1998 |
Forbes B, Lansley AB. Differences in drug transport across bronchial and gastrointestinal drug absorption models Journal of Pharmacy and Pharmacology. 50: 96-96. DOI: 10.1111/J.2042-7158.1998.Tb02296.X |
0.346 |
|
| Show low-probability matches. |